INFI Annual Retained Earnings
-$855.95 M
-$44.37 M-5.47%
31 December 2022
Summary:
As of January 21, 2025, INFI annual retained earnings is -$855.95 million, with the most recent change of -$44.37 million (-5.47%) on December 31, 2022. During the last 3 years, it has fallen by -$130.12 million (-17.93%).INFI Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Quarterly Retained Earnings
-$876.95 M
-$9.96 M-1.15%
30 June 2023
Summary:
As of January 21, 2025, INFI quarterly retained earnings is -$876.95 million, with the most recent change of -$9.96 million (-1.15%) on June 30, 2023. Over the past year, it has dropped by -$40.95 million (-4.90%).INFI Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.5% | -4.9% |
| 3 y3 years | -17.9% | -17.5% |
| 5 y5 years | -28.2% | -28.2% |
INFI Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | +4237.8% | +4005.0% |
Infinity Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | -$876.95 M(+1.1%) |
| Mar 2023 | - | -$867.00 M(+1.3%) |
| Dec 2022 | -$855.95 M(+5.5%) | -$855.95 M(+1.1%) |
| Sept 2022 | - | -$846.72 M(+1.3%) |
| June 2022 | - | -$836.00 M(+1.5%) |
| Mar 2022 | - | -$824.02 M(+1.5%) |
| Dec 2021 | -$811.58 M(+5.9%) | -$811.58 M(+1.5%) |
| Sept 2021 | - | -$799.93 M(+1.4%) |
| June 2021 | - | -$789.22 M(+1.4%) |
| Mar 2021 | - | -$777.95 M(+1.5%) |
| Dec 2020 | -$766.32 M(+5.6%) | -$766.32 M(+1.4%) |
| Sept 2020 | - | -$755.72 M(+1.3%) |
| June 2020 | - | -$746.19 M(+1.3%) |
| Mar 2020 | - | -$736.72 M(+1.5%) |
| Dec 2019 | -$725.83 M(+6.9%) | -$725.83 M(+1.6%) |
| Sept 2019 | - | -$714.45 M(+1.6%) |
| June 2019 | - | -$703.03 M(+1.5%) |
| Mar 2019 | - | -$692.52 M(+2.0%) |
| Dec 2018 | -$678.77 M(+1.7%) | -$678.77 M(+1.2%) |
| Sept 2018 | - | -$670.55 M(-2.0%) |
| June 2018 | - | -$683.93 M(+1.0%) |
| Mar 2018 | - | -$676.97 M(+1.4%) |
| Dec 2017 | -$667.52 M(+6.7%) | -$667.52 M(+1.1%) |
| Sept 2017 | - | -$660.22 M(+1.1%) |
| June 2017 | - | -$653.12 M(+2.7%) |
| Mar 2017 | - | -$636.16 M(+1.7%) |
| Dec 2016 | -$625.69 M(+5.1%) | -$625.69 M(+3.8%) |
| Sept 2016 | - | -$602.76 M(+3.3%) |
| June 2016 | - | -$583.26 M(-8.3%) |
| Mar 2016 | - | -$636.25 M(+6.8%) |
| Dec 2015 | -$595.59 M(+27.5%) | -$595.59 M(+7.0%) |
| Sept 2015 | - | -$556.40 M(-7.1%) |
| June 2015 | - | -$598.94 M(+6.9%) |
| Mar 2015 | - | -$560.51 M(+20.0%) |
| Dec 2014 | -$467.21 M(+3.9%) | -$467.21 M(+9.5%) |
| Sept 2014 | - | -$426.87 M(-19.5%) |
| June 2014 | - | -$530.09 M(+7.7%) |
| Mar 2014 | - | -$492.06 M(+9.4%) |
| Dec 2013 | -$449.80 M(+39.2%) | -$449.80 M(+7.9%) |
| Sept 2013 | - | -$416.87 M(+8.9%) |
| June 2013 | - | -$382.93 M(+9.3%) |
| Mar 2013 | - | -$350.34 M(+8.5%) |
| Dec 2012 | -$323.02 M(+20.1%) | -$323.02 M(+17.0%) |
| Sept 2012 | - | -$276.03 M(-6.3%) |
| June 2012 | - | -$294.43 M(+5.2%) |
| Mar 2012 | - | -$279.77 M(+4.0%) |
| Dec 2011 | -$269.05 M | -$269.05 M(+5.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | -$254.99 M(+4.9%) |
| June 2011 | - | -$243.05 M(+5.1%) |
| Mar 2011 | - | -$231.32 M(+1.0%) |
| Dec 2010 | -$229.01 M(+27.2%) | -$229.01 M(+5.4%) |
| Sept 2010 | - | -$217.26 M(+10.8%) |
| June 2010 | - | -$196.01 M(+3.3%) |
| Mar 2010 | - | -$189.76 M(+5.4%) |
| Dec 2009 | -$180.03 M(+20.9%) | -$180.03 M(+3.8%) |
| Sept 2009 | - | -$173.49 M(+5.7%) |
| June 2009 | - | -$164.17 M(+7.4%) |
| Mar 2009 | - | -$152.84 M(+2.7%) |
| Dec 2008 | -$148.89 M(-13.7%) | -$148.89 M(-23.9%) |
| Sept 2008 | - | -$195.66 M(+6.8%) |
| June 2008 | - | -$183.27 M(+6.5%) |
| Mar 2008 | - | -$172.12 M(-0.2%) |
| Dec 2007 | -$172.55 M(+11.1%) | -$172.55 M(+4.8%) |
| Sept 2007 | - | -$164.70 M(+1.2%) |
| June 2007 | - | -$162.70 M(+2.6%) |
| Mar 2007 | - | -$158.54 M(+2.1%) |
| Dec 2006 | -$155.31 M(+22.4%) | -$155.31 M(+3.6%) |
| Sept 2006 | - | -$149.88 M(+17.7%) |
| June 2006 | - | -$127.35 M(+3.6%) |
| Mar 2006 | - | -$122.93 M(-3.1%) |
| Dec 2005 | -$126.86 M(+27.2%) | -$126.86 M(+19.7%) |
| Sept 2005 | - | -$105.99 M(+0.3%) |
| June 2005 | - | -$105.64 M(+1.3%) |
| Mar 2005 | - | -$104.28 M(+4.6%) |
| Dec 2004 | -$99.73 M(-3.8%) | -$99.73 M(-1.4%) |
| Sept 2004 | - | -$101.10 M(-0.7%) |
| June 2004 | - | -$101.85 M(-0.7%) |
| Mar 2004 | - | -$102.59 M(-1.0%) |
| Dec 2003 | -$103.63 M(-1.0%) | -$103.63 M(-1.4%) |
| Sept 2003 | - | -$105.13 M(-0.5%) |
| June 2003 | - | -$105.67 M(+1.2%) |
| Mar 2003 | - | -$104.41 M(-0.3%) |
| Dec 2002 | -$104.69 M(+145.9%) | -$104.69 M(+94.5%) |
| Sept 2002 | - | -$53.81 M(+1.5%) |
| June 2002 | - | -$53.00 M(+22.3%) |
| Mar 2002 | - | -$43.34 M(+1.8%) |
| Dec 2001 | -$42.58 M(+35.5%) | -$42.58 M(+4.0%) |
| Sept 2001 | - | -$40.94 M(+18.6%) |
| June 2001 | - | -$34.52 M(+2.6%) |
| Mar 2001 | - | -$33.63 M(+7.0%) |
| Dec 2000 | -$31.43 M(+59.3%) | -$31.43 M(+0.4%) |
| Sept 2000 | - | -$31.31 M(+2.1%) |
| June 2000 | - | -$30.68 M(+43.6%) |
| Mar 2000 | - | -$21.36 M |
| Dec 1999 | -$19.73 M | - |
FAQ
- What is Infinity Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals annual retained earnings year-on-year change?
- What is Infinity Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals quarterly retained earnings year-on-year change?
What is Infinity Pharmaceuticals annual retained earnings?
The current annual retained earnings of INFI is -$855.95 M
What is the all time high annual retained earnings for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high annual retained earnings is -$19.73 M
What is Infinity Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, INFI annual retained earnings has changed by -$44.37 M (-5.47%)
What is Infinity Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of INFI is -$876.95 M
What is the all time high quarterly retained earnings for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high quarterly retained earnings is -$21.36 M
What is Infinity Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, INFI quarterly retained earnings has changed by -$40.95 M (-4.90%)